Showing 2,061 - 2,080 results of 18,079 for search 'significantly ((((((we decrease) OR (a decrease))) OR (larger decrease))) OR (teer decrease))', query time: 0.46s Refine Results
  1. 2061

    Data Sheet 1_DYRK1A roles in human neural progenitors.docx by Jeremie Courraud (20871932)

    Published 2025
    “…In addition, DYRK1A-KD led to a reduction in p21 protein levels, despite an increase in the expression of a minor transcript variant for this gene, and a decrease in ERK pathway activation.…”
  2. 2062
  3. 2063

    S1 Data - by Bowen Deng (3123237)

    Published 2024
    “…</p><p>Results</p><p>Among 1,523 eligible patients, 227 (14.9%) died within 30 days. We identified 4 longitudinal trajectories of blood glucose, including class 1 (a low initial average blood glucose level with steady trend within 24 hours), class 2 (a high initial average blood glucose with gently decreased trend), class 3 (the highest initial average blood glucose with rapidly decreased trend) and class 4 (a high initial average blood glucose level with the trend that increased at first and then decreased). …”
  4. 2064

    Characteristics of AMI patients with DM. by Bowen Deng (3123237)

    Published 2024
    “…</p><p>Results</p><p>Among 1,523 eligible patients, 227 (14.9%) died within 30 days. We identified 4 longitudinal trajectories of blood glucose, including class 1 (a low initial average blood glucose level with steady trend within 24 hours), class 2 (a high initial average blood glucose with gently decreased trend), class 3 (the highest initial average blood glucose with rapidly decreased trend) and class 4 (a high initial average blood glucose level with the trend that increased at first and then decreased). …”
  5. 2065

    Four grid table. by Xiaoling Zhong (181270)

    Published 2025
    “…These methods were used to evaluate whether there is a significant association between finasteride drug use and AEs. …”
  6. 2066

    Four major algorithms used for signal detection. by Xiaoling Zhong (181270)

    Published 2025
    “…These methods were used to evaluate whether there is a significant association between finasteride drug use and AEs. …”
  7. 2067

    Presentation 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated... by Xiaokang Wang (733379)

    Published 2025
    “…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”
  8. 2068

    Table 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated signall... by Xiaokang Wang (733379)

    Published 2025
    “…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”
  9. 2069
  10. 2070
  11. 2071
  12. 2072
  13. 2073

    S1 Data - by Hao Deng (409186)

    Published 2024
    “…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
  14. 2074

    Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

    Published 2024
    “…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
  15. 2075
  16. 2076
  17. 2077
  18. 2078

    Data. by Su Hwan Park (15158181)

    Published 2025
    “…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”
  19. 2079

    Baseline characteristics of patients. by Su Hwan Park (15158181)

    Published 2025
    “…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”
  20. 2080